Skip to main content

ADAR1 Capital Management, LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1940272 AUSTIN, TX

Position in CRVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,749,488
+$463,497 QoQ
Shares Held
117,101
+33.2% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#58
of 172 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Derivatives in CRVS

reported options exposure · as of Dec 31, 2024
CallValue
$53,500
CallShares
10,000
PutValue
$80,250
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,452,202 across 192 Biotechnology names. CRVS ranks #111 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,749,488 117,101
2026-03-31 $1,285,991 87,901
2025-12-31 $3,587,237 465,875
2024-12-31 $53,500 10,000
2024-12-31 $80,250 15,000